Altria (a.k.a. Philip Morris USA) has lost its international presence, leaving only the dying U.S. smoking market to support the company. It's also moved from its swanky New York digs to humbler new headquarters in Richmond, Va.
The growing pains certainly showed in Altria's first-quarter earnings results, which were released yesterday. Net revenue inched up just 2.8% from last year, while reported earnings per share dropped by 12.1%. Even after adjusting for the spinoff charges and costs associated with relocating, the company's 12.1% increase in earnings per share from continuing operations paled in comparison to half-brother PMI's recent 29% earnings jump.
Now that its PMI spinoff is complete, the reorganized Altria forecasts that its new Southern headquarters will improve its cost structure. Overall, Philip Morris USA cigarette volume dropped by 1.2% year over year, with a 0.5% increase in overall market share. Marlboro has maintained its market-leader status, with a 0.7% increase in market share for the quarter. That brought its Marlboro market share to 41.5%, and overall Philip Morris USA market share to 50.9%.
The company is also looking to expand its U.S. presence and take advantage of Marlboro brand strength, testing its new "Marlboro Snus" product in Dallas. Marlboro Snus is described as "a spit-free, smokeless tobacco pouch designed especially for adult smokers." Not quite appealing to me, but it shows the initiatives the company is taking to roll out new products that further capitalize on its strong Marlboro brand.
Imagine if other big global names like Coca-Cola
Of course, lawsuits are the biggest ongoing risk for Altria, a concern that triggered the spinoff of PMI in the first place. Even with a revised cost structure, Altria's lack of ongoing growth will continue to hurt results. Its headquarters may have moved south, but the company will have to work hard to keep future earnings from following suit.
For related Foolishness: